Background: The episodic sub-episode block sums split-integrated weighted average-averaged gene overexpression tropy quotient (esebssiwaagoT Q ) is a measure of the 5′ → 3′ reading direction intergene distance tropy that needs to be overcome for horizontal alignment of a gene for maximal transcription; and it is also an arbitrary unit measure of the intracellular pressure needed for maximal gene expression. In this study, B-cell differentiation is studied by esebssiwaagoT Q -based pressuromodulation mapping of B-cell stage marker genes. Methods: Locations of 25 B-cell differentiation stage genes, and locations of downstream and upstream genes were mined at GeneCards and at LNCipedia, pseudogenes included and enhancers excluded. The esebssiwaagoT Q s for each gene were determined. A pressuromodulation map was generated by arranging overexpressed B-cell stage marker genes in descending and ascending order by esebssiwaagoT Q in reference to periods of B-cell polarization.
Results: The gene esebssiwaagoT Q s are CD34 0.65 (0.648), PRDM1 0.36 (0.356), PTPRC 0.35 (0.345), MKI67 0.33 (0.329), ENPP1 0.31 (0.308), RAG2 0.31 (0.306), MS4A1 0.30 (0.299), PCNA 0.28 (0.285), ESPL1 0.28 (0.275), CD79B 0.27 (0.271), AICDA 0.27 (0.266), CD40 0.26 (0.257), APOBEC3A/-B 0.22 (0.216), CD38 0.21 (0.212), CD27 0.19 (0.194), APOBEC3C/−D/-F/−G 0.17 (0.173), CD19 0.15 (0.153), RAG1 0.14 (0.139), CD79A 0.14 (0.137), CR2 0.11 (0.109), and APOBEC3H 0.10 (0.102); these are pressuromodulation mapped in reference to B-cell polarization state and differentiation stage.
Conclusions:The esebssiwaagoT Q -based pressuromodulation map of B-cell differentiation simulates the in vivo B-cell maturation process for the classical pathway (T-cell mediated pressuromodulation effect pathway) and applies to the parallel non-classical pathway (T-cell independent antigen-mediated pressuromodulation effect pathway). Henceforth the B-cell pressuromodulation map can be utilized as the template for the study of specific B-cell events including bi-allelic V(D)J gene recombination, IGHM internal consensus recognition sequence, IGHD homologous recombination or initial allelic exclusion, further consensus recognition sequence isotype switchings, and somatic hypermutation, as in Part II.